Can a buddy system help head and neck cancer patients? new study aims to find out
NCT ID NCT07664241
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This trial tests whether a one-on-one peer support program is feasible for people with head and neck cancer. Patients (mentees) are matched with cancer survivors (mentors) for emotional and informational support. The study will enroll 56 participants and measure how many actually meet their mentor and how satisfied they are. It does not test whether the program improves survival or cancer outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- peer support program
- What this could lead to
- If successful, this could show that a structured peer support program is a practical way to improve emotional and informational support for head and neck cancer patients.
- What could go wrong
- This is a small feasibility study (56 participants) that hasn't started recruiting yet. It only measures whether people use the program, not whether it improves health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT HEAD AND NECK NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Texting your symptoms: a digital coach for cancer side effects?
- New program aims to make cancer surgery safer for seniors
- Yoga may ease cancer treatment side effects for patients and partners
- FITBIT FOR CANCER: STUDY TESTS IF STEP COUNTS PREDICT SURVIVAL
- Breathing device use after throat surgery under the microscope
- New drug combo targets tumors in patients with organ failure